Alessandro Gamboni
Lugo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax).
Journal: Frontiers in immunology
Published: March 21, 2024
Frequency of actionable alterations in epidermal growth factor receptor (EGFR) wild type non-small cell lung cancer: experience of the Wide Catchment Area of Romagna (AVR).
Journal: Journal of thoracic disease
Published: September 21, 2018
Impact of TP53 Mutations on Outcome in EGFR-Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 19, 2016
Prognostic Evaluation of Disease Outcome in Solid Tumors Investigated With 64Cu-ATSM PET/CT.
Journal: Clinical nuclear medicine
Published: October 09, 2015
Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy.
Journal: Clinical lung cancer
Published: September 04, 2015
Gene mutation analysis in EGFR wild type NSCLC responsive to erlotinib: are there features to guide patient selection?
Journal: International journal of molecular sciences
Published: October 17, 2014
Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?
Journal: Neuro-oncology practice
Published: March 29, 2014
Gemcitabine and paclitaxel combination as second-line chemotherapy in patients with small-cell lung cancer: a phase II study.
Journal: Clinical lung cancer
Published: January 18, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026